Considering sex as a biological variable in preclinical research

Leah R. Miller, Cheryl Marks, Jill B. Becker, Patricia D. Hurn, Wei Jung Chen, Teresa Woodruff, Margaret M. McCarthy, Farida Sohrabji, Londa Schiebinger, Cora Lee Wetherington, Susan Makris, Arthur P. Arnold, Gillian Einstein, Virginia M Miller, Kathryn Sandberg, Susan Maier, Terri L. Cornelison, Janine A. Clayton

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

In June2015, the National Institutes of Health (NIH)released a Guidenotice (NOT-OD-15-102) that highlighted the expectation of the NIH that the possible role of sex as a biologicvariablebe factored into research design, analyses, and reporting of vertebrate animal and human studies. Anticipating these guidelines, the NIH Office of Research on Women's Health, in October 2014, convened key stakeholders to discuss methods and techniques for integrating sex as a biologic variable in preclinical research. The workshop focused on practical methods, experimental design, and approaches to statistical analyses in the use of both male and female animals, cells, and tissues in preclinical research. Workshop participants also considered gender as a modifier of biology. This article builds on the works hopandismeant as a guide to preclinical investigators as they consider methods and techniques for inclusion of both sexes in preclinical research and is not intended to prescribe exhaustive/specific approaches for compliance with the new NIH policy. -Miller, L. R., Marks, C., Becker, J.B., Hurn, P.D., Chen, W.-J., Woodruff, T., McCarthy, M.M., Sohrabji, F., Schiebinger, L., Wetherington, C.L., Makris, S., Arnold, A. P., Einstein, G., Miller, V. M., Sandberg, K., Maier, S., Cornelison, T. L., Clayton, J. A. Considering sex as a biological variable in preclinical research.

Original languageEnglish (US)
Pages (from-to)29-34
Number of pages6
JournalFASEB Journal
Volume31
Issue number1
DOIs
StatePublished - Jan 1 2017

Fingerprint

National Institutes of Health (U.S.)
Research
Health
Research Design
Animals
Education
Women's Health
Health Policy
Vertebrates
Design of experiments
Research Personnel
Guidelines
Tissue

Keywords

  • Gender
  • Methods
  • Sex differences
  • Sex influences

ASJC Scopus subject areas

  • Biotechnology
  • Biochemistry
  • Molecular Biology
  • Genetics

Cite this

Miller, L. R., Marks, C., Becker, J. B., Hurn, P. D., Chen, W. J., Woodruff, T., ... Clayton, J. A. (2017). Considering sex as a biological variable in preclinical research. FASEB Journal, 31(1), 29-34. https://doi.org/10.1096/fj.201600781R

Considering sex as a biological variable in preclinical research. / Miller, Leah R.; Marks, Cheryl; Becker, Jill B.; Hurn, Patricia D.; Chen, Wei Jung; Woodruff, Teresa; McCarthy, Margaret M.; Sohrabji, Farida; Schiebinger, Londa; Lee Wetherington, Cora; Makris, Susan; Arnold, Arthur P.; Einstein, Gillian; Miller, Virginia M; Sandberg, Kathryn; Maier, Susan; Cornelison, Terri L.; Clayton, Janine A.

In: FASEB Journal, Vol. 31, No. 1, 01.01.2017, p. 29-34.

Research output: Contribution to journalArticle

Miller, LR, Marks, C, Becker, JB, Hurn, PD, Chen, WJ, Woodruff, T, McCarthy, MM, Sohrabji, F, Schiebinger, L, Lee Wetherington, C, Makris, S, Arnold, AP, Einstein, G, Miller, VM, Sandberg, K, Maier, S, Cornelison, TL & Clayton, JA 2017, 'Considering sex as a biological variable in preclinical research', FASEB Journal, vol. 31, no. 1, pp. 29-34. https://doi.org/10.1096/fj.201600781R
Miller LR, Marks C, Becker JB, Hurn PD, Chen WJ, Woodruff T et al. Considering sex as a biological variable in preclinical research. FASEB Journal. 2017 Jan 1;31(1):29-34. https://doi.org/10.1096/fj.201600781R
Miller, Leah R. ; Marks, Cheryl ; Becker, Jill B. ; Hurn, Patricia D. ; Chen, Wei Jung ; Woodruff, Teresa ; McCarthy, Margaret M. ; Sohrabji, Farida ; Schiebinger, Londa ; Lee Wetherington, Cora ; Makris, Susan ; Arnold, Arthur P. ; Einstein, Gillian ; Miller, Virginia M ; Sandberg, Kathryn ; Maier, Susan ; Cornelison, Terri L. ; Clayton, Janine A. / Considering sex as a biological variable in preclinical research. In: FASEB Journal. 2017 ; Vol. 31, No. 1. pp. 29-34.
@article{2ddfc275f36d4202bbecf61e3596421a,
title = "Considering sex as a biological variable in preclinical research",
abstract = "In June2015, the National Institutes of Health (NIH)released a Guidenotice (NOT-OD-15-102) that highlighted the expectation of the NIH that the possible role of sex as a biologicvariablebe factored into research design, analyses, and reporting of vertebrate animal and human studies. Anticipating these guidelines, the NIH Office of Research on Women's Health, in October 2014, convened key stakeholders to discuss methods and techniques for integrating sex as a biologic variable in preclinical research. The workshop focused on practical methods, experimental design, and approaches to statistical analyses in the use of both male and female animals, cells, and tissues in preclinical research. Workshop participants also considered gender as a modifier of biology. This article builds on the works hopandismeant as a guide to preclinical investigators as they consider methods and techniques for inclusion of both sexes in preclinical research and is not intended to prescribe exhaustive/specific approaches for compliance with the new NIH policy. -Miller, L. R., Marks, C., Becker, J.B., Hurn, P.D., Chen, W.-J., Woodruff, T., McCarthy, M.M., Sohrabji, F., Schiebinger, L., Wetherington, C.L., Makris, S., Arnold, A. P., Einstein, G., Miller, V. M., Sandberg, K., Maier, S., Cornelison, T. L., Clayton, J. A. Considering sex as a biological variable in preclinical research.",
keywords = "Gender, Methods, Sex differences, Sex influences",
author = "Miller, {Leah R.} and Cheryl Marks and Becker, {Jill B.} and Hurn, {Patricia D.} and Chen, {Wei Jung} and Teresa Woodruff and McCarthy, {Margaret M.} and Farida Sohrabji and Londa Schiebinger and {Lee Wetherington}, Cora and Susan Makris and Arnold, {Arthur P.} and Gillian Einstein and Miller, {Virginia M} and Kathryn Sandberg and Susan Maier and Cornelison, {Terri L.} and Clayton, {Janine A.}",
year = "2017",
month = "1",
day = "1",
doi = "10.1096/fj.201600781R",
language = "English (US)",
volume = "31",
pages = "29--34",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "1",

}

TY - JOUR

T1 - Considering sex as a biological variable in preclinical research

AU - Miller, Leah R.

AU - Marks, Cheryl

AU - Becker, Jill B.

AU - Hurn, Patricia D.

AU - Chen, Wei Jung

AU - Woodruff, Teresa

AU - McCarthy, Margaret M.

AU - Sohrabji, Farida

AU - Schiebinger, Londa

AU - Lee Wetherington, Cora

AU - Makris, Susan

AU - Arnold, Arthur P.

AU - Einstein, Gillian

AU - Miller, Virginia M

AU - Sandberg, Kathryn

AU - Maier, Susan

AU - Cornelison, Terri L.

AU - Clayton, Janine A.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - In June2015, the National Institutes of Health (NIH)released a Guidenotice (NOT-OD-15-102) that highlighted the expectation of the NIH that the possible role of sex as a biologicvariablebe factored into research design, analyses, and reporting of vertebrate animal and human studies. Anticipating these guidelines, the NIH Office of Research on Women's Health, in October 2014, convened key stakeholders to discuss methods and techniques for integrating sex as a biologic variable in preclinical research. The workshop focused on practical methods, experimental design, and approaches to statistical analyses in the use of both male and female animals, cells, and tissues in preclinical research. Workshop participants also considered gender as a modifier of biology. This article builds on the works hopandismeant as a guide to preclinical investigators as they consider methods and techniques for inclusion of both sexes in preclinical research and is not intended to prescribe exhaustive/specific approaches for compliance with the new NIH policy. -Miller, L. R., Marks, C., Becker, J.B., Hurn, P.D., Chen, W.-J., Woodruff, T., McCarthy, M.M., Sohrabji, F., Schiebinger, L., Wetherington, C.L., Makris, S., Arnold, A. P., Einstein, G., Miller, V. M., Sandberg, K., Maier, S., Cornelison, T. L., Clayton, J. A. Considering sex as a biological variable in preclinical research.

AB - In June2015, the National Institutes of Health (NIH)released a Guidenotice (NOT-OD-15-102) that highlighted the expectation of the NIH that the possible role of sex as a biologicvariablebe factored into research design, analyses, and reporting of vertebrate animal and human studies. Anticipating these guidelines, the NIH Office of Research on Women's Health, in October 2014, convened key stakeholders to discuss methods and techniques for integrating sex as a biologic variable in preclinical research. The workshop focused on practical methods, experimental design, and approaches to statistical analyses in the use of both male and female animals, cells, and tissues in preclinical research. Workshop participants also considered gender as a modifier of biology. This article builds on the works hopandismeant as a guide to preclinical investigators as they consider methods and techniques for inclusion of both sexes in preclinical research and is not intended to prescribe exhaustive/specific approaches for compliance with the new NIH policy. -Miller, L. R., Marks, C., Becker, J.B., Hurn, P.D., Chen, W.-J., Woodruff, T., McCarthy, M.M., Sohrabji, F., Schiebinger, L., Wetherington, C.L., Makris, S., Arnold, A. P., Einstein, G., Miller, V. M., Sandberg, K., Maier, S., Cornelison, T. L., Clayton, J. A. Considering sex as a biological variable in preclinical research.

KW - Gender

KW - Methods

KW - Sex differences

KW - Sex influences

UR - http://www.scopus.com/inward/record.url?scp=85009732706&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009732706&partnerID=8YFLogxK

U2 - 10.1096/fj.201600781R

DO - 10.1096/fj.201600781R

M3 - Article

VL - 31

SP - 29

EP - 34

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 1

ER -